James Francis McCabe

Title: James Francis McCabe: Innovator in Pharmaceutical Chemistry

Introduction

James Francis McCabe is a notable inventor based in Hoddesdon, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target the central nervous system.

Latest Patents

McCabe holds a patent for a substituted triazolo-pyridazine derivative, specifically 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine, along with its pharmaceutically acceptable salts. This compound serves as a selective ligand for GABA receptors, which are crucial in the treatment of various disorders affecting the central nervous system. He has 1 patent to his name.

Career Highlights

James McCabe is currently associated with Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts in pharmaceuticals. His work has the potential to impact the treatment of neurological disorders significantly.

Collaborations

Throughout his career, McCabe has collaborated with esteemed colleagues such as William Robert Carling and Jose Luis Castro Pineiro. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

James Francis McCabe exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions, particularly in developing selective ligands for GABA receptors, highlight the importance of research in improving treatments for central nervous system disorders.